- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03116581
Altruistic Decisions
Study on the Parameters That Influence Perceptual Decisions
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
Bron, Frankrijk, 69677
- CH Le Vinatier
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Aged between 18 and 35
- Right-handed
- French
- Normal vision or corrected by contact lenses
Exclusion Criteria:
- Contraindications to the MEG examination
- Presence of a perceptual disorder (vision) or motor impairing the capacity to carry out the tasks requested (including dyschromatopsia and achromatopsia).
- Taking of medical treatment in progress (excluding contraceptive pill).
- Known neurological or psychiatric history or disorders.
- Participants in an exclusion period for any other research.
- Participants who do not benefit from social protection.
- Participants refusing to be informed of the results of the medical examination.
- Participants who refuse to be informed of the possible detection of an anomaly.
- Participants with MRI contraindications
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Fundamentele wetenschap
- Toewijzing: Niet-gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Ander: Vicarious reward
If a decision influences the well-being of another (through monetary payoff), the decision making processes should differ from a decision that would influences only oneself. The difference will be reflected in the reaction-times and in the accuracy of the response to the task. The drift diffusion models care then used to estimate le decision parameter in each condition and understand which parameter is influenced by the beneficiary of the payoff associated with a decision. Once the decision parameter characterized with behavioral experiment, the study aims to better understand the neural network sustaining the influence of others on the decision making process, by assessing the neural activity related to the decision making processes. Also, the research compares how the brain responses for payoff for others and payoffs for oneself, specially to confirm that these responses are located in different areas of the Anterior cingulate Cortex. |
Random-dots tasks: dots appear and move, most have a random trajectory but a given proportion of them move coherently to the same direction.
Both behavioral task (audience effect and vicarious reward) will be studied in fMRI (functional Magnetic Resonance Imagery). The same paradigms used in the behavioral experiment will be adapted for fMRI. Audience Effect experiment: trials will last for 10 seconds maximum. With 80 trials for each condition (public easy, public difficult, private easy and private difficult), the task will count a total of 320 trials and have a 54 minutes duration, in 3 runs of 17 minutes each. Vicarious Reward experiment: trials will have a 10 seconds maximum duration. Using 40 trials for each condition (other low payoff, other high payoff, self low payoff, self high payoff, control condition), the task will have a total of 200 trials and last for 54 minutes, in 6 runs of 9 minutes each. Both behavioral task (audience effect and vicarious reward) will be studied in MEG (MagnetoEncephaloGraphy). The same paradigms used in the behavioral experiment will be used in MEG. Audience Effect experiment: trials will last for 7 seconds maximum. With 100 trials for each condition (public easy, public difficult, private easy and private difficult), the task will count a total of 400 trials and have a 47 minutes duration. Every 100 trials (about 12 minutes of tasks), a break will be proposed to the participants. Vicarious Reward experiment: trials will have a 7.2 seconds maximum duration. Using 75 trials for each condition (other low payoff, other high payoff, self low payoff, self high payoff, control condition), the task will have a total of 375 trials and last for 45 minutes. Every 125 trials (every 15 minutes), a break will be proposed to the participants. |
|
Ander: Audience effect
In order to clarify the complex changes in the decision-making processes induced by simple observation by others (audience) , the experiment have two levels of difficulty .
These levels of difficulty will be determined in such a way as to achieve better 'public' performance than 'private' when the task is easy (high level of consistency) and poor performance when the task is difficult (low level of coherence) As described in the literature in psychology.
Drift diffusion models will be used to better understand the variations in performance, to decipher between a modulation of the diffusion velocity and or of the decision threshold.
This study will help characterize how observation by others modulates performance.
Once the decision parameter characterized with behavioral experiment, the study aims to better understand the neural network sustaining the impact of observation by others on the decision making process.
|
Random-dots tasks: dots appear and move, most have a random trajectory but a given proportion of them move coherently to the same direction.
Both behavioral task (audience effect and vicarious reward) will be studied in fMRI (functional Magnetic Resonance Imagery). The same paradigms used in the behavioral experiment will be adapted for fMRI. Audience Effect experiment: trials will last for 10 seconds maximum. With 80 trials for each condition (public easy, public difficult, private easy and private difficult), the task will count a total of 320 trials and have a 54 minutes duration, in 3 runs of 17 minutes each. Vicarious Reward experiment: trials will have a 10 seconds maximum duration. Using 40 trials for each condition (other low payoff, other high payoff, self low payoff, self high payoff, control condition), the task will have a total of 200 trials and last for 54 minutes, in 6 runs of 9 minutes each. Both behavioral task (audience effect and vicarious reward) will be studied in MEG (MagnetoEncephaloGraphy). The same paradigms used in the behavioral experiment will be used in MEG. Audience Effect experiment: trials will last for 7 seconds maximum. With 100 trials for each condition (public easy, public difficult, private easy and private difficult), the task will count a total of 400 trials and have a 47 minutes duration. Every 100 trials (about 12 minutes of tasks), a break will be proposed to the participants. Vicarious Reward experiment: trials will have a 7.2 seconds maximum duration. Using 75 trials for each condition (other low payoff, other high payoff, self low payoff, self high payoff, control condition), the task will have a total of 375 trials and last for 45 minutes. Every 125 trials (every 15 minutes), a break will be proposed to the participants. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Modulation of the decisional parameter by the payoff conditions
Tijdsspanne: 1 hour
|
behavioral data (reaction-times and accuracy) are collected and the decision parameter can be estimated from them using Drift Diffusion Models
|
1 hour
|
|
Modulation of the decisional parameter by the beneficiary conditions
Tijdsspanne: 1 hour
|
behavioral data (reaction-times and accuracy) are collected and the decision parameter can be estimated from them using Drift Diffusion Models
|
1 hour
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Event-Related potentials
Tijdsspanne: 1 hour
|
study of the time-locked brain activity
|
1 hour
|
|
Time-frequency brain responses
Tijdsspanne: 1 hour
|
study of the oscillatory activity elicited in the brain
|
1 hour
|
|
BOLD
Tijdsspanne: 1 hour
|
Variation of the blood-oxygen-level dependent (BOLD) signal
|
1 hour
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Caroline DEMILY, MD, CH Le Vinatier
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Andere studie-ID-nummers
- 69HCL16_0680
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Gezond
-
University Hospital, GhentWervingHealthy Controls Group - Leeftijd en geslacht afgestemd | Herhaaldelijk negatief denkenBelgië
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences InstituteWervingHealthy Controls Group - Leeftijd en geslacht afgestemd | Borderline persoonlijkheidsstoornis (BPS)Verenigde Staten
-
Hacettepe UniversityWervingBronchiëctasie Volwassene | Healthy Controls Group - Leeftijd en geslacht afgestemdKalkoen
-
Hasselt UniversityWervingMultiple sclerose | Healthy Controls Group - Leeftijd en geslacht afgestemdBelgië, Italië, Spanje
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Brain and Behavior...WervingOpioïdengebruiksstoornis | Healthy Controls Group - Leeftijd en geslacht afgestemdVerenigde Staten
-
University of LeicesterNational Institute for Health Research, United KingdomVoltooidPatiënten met hartfalen en behouden ejectiefractie - HFpEF | Patiënten met hartfalen met verminderde ejectiefractie - HFrEF | Healthy Controls Group - Leeftijd en geslacht afgestemd
-
University of North Carolina, Chapel HillNational Institute of Neurological Disorders and Stroke (NINDS)WervingMusculoskeletale pijn | Fibromyalgie | Healthy Controls Group - Leeftijd en geslacht afgestemdVerenigde Staten
-
Gulseren Demir KarakilicVoltooidFibromyalgie Syndroom | Healthy Controls Group - Leeftijd en geslacht afgestemdKalkoen
-
University Hospital, GrenobleUniversity Hospital, Clermont-Ferrand; Grenoble Institut des NeurosciencesBeëindigdZiekte van Parkinson | Healthy Controls Group - Leeftijd en geslacht afgestemdFrankrijk
-
Abant Izzet Baysal UniversityVoltooidHealthy Controls Group - Leeftijd en geslacht afgestemd | Ziekte van Alzheimer (AD)Turkije (Türkiye)
Klinische onderzoeken op Behavior
-
Manish RajbanshiVoltooidPreventie van Internetverslaving onder Hogere Secundaire SchoolstudentenNepal
-
Hospices Civils de LyonWervingHyperekplexieFrankrijk
-
Utah State UniversityOnbekendTrichotillomanieVerenigde Staten
-
Oregon Research InstituteNational Institute on Drug Abuse (NIDA)VoltooidEvaluatie van een op video gebaseerde mediaserie om effectief ouderschap te bevorderen (ParentMedia)Disruptieve gedragsproblemen bij kinderenVerenigde Staten
-
Shanghai Ninth People's Hospital Affiliated to...Werving
-
Second Affiliated Hospital, School of Medicine,...Voltooid
-
Chestnut Health SystemsNational Institute on Drug Abuse (NIDA)VoltooidDrugsmisbruik | Substantie afhankelijkheidVerenigde Staten
-
International Centre for Diarrhoeal Disease Research...University of Chicago; Marquette University; Mailman School of Public HealthWervingLuchtvervuiling | Cardiopulmonale functie | Immuunfunctie | mHealth-interventieBangladesh
-
Milton S. Hershey Medical CenterVoltooidAutisme Spectrum Stoornis | OntwikkelingsachterstandVerenigde Staten
-
University Hospital, BrestWervingVoortijdige geboorteFrankrijk